Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

9.13
Delayed Data
As of Jul 22
 +0.08 / +0.88%
Today’s Change
4.50
Today|||52-Week Range
11.69
+35.86%
Year-to-Date
5 Reasons Biotech Stocks Are Smart Investments
2:09pm / MotleyFool.com - Paid Partner Content
Why Inovio Pharmaceuticals' Stock Plunged in June
Jul 14 / MotleyFool.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close9.05
Today’s open9.13
Day’s range9.00 - 9.25
Volume553,698
Average volume (3 months)1,672,136
Market cap$669.7M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...-0.81-4.19%
RTRXRetrophin Inc+0.35+1.97%
ANIPANI Pharmaceuticals ...+0.48+0.82%
ATRAAtara Biotherapeutic...+0.22+0.99%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts

Partner Offers

Search for Jobs